Windlas Biotech Limited (WINDLAS)

1,049

INR
+17.40(+1.69%)
As of December 26, 2024 9:59:00 AM

Windlas Biotech Limited Share Price Information

24 hour Low and High

Low: 1016.25
High: 1064.3

All time High

8230.60

Price Change 1h

+₹17.40 +1.69%

Price Change 1d

+₹17.40 +1.69%

Price Change 1w

+₹23.75 +2.32%

Windlas Biotech Limited Market Information

Exchange

NSE

Market Cap

₹2158.39 Cr

About Windlas Biotech Limited Share

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1154

CEO

Ms. Komal Gupta

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

    FAQs

    Windlas Biotech Limited (WINDLAS)

    1,049

    INR
    +17.40(+1.69%)
    As of December 26, 2024 9:59:00 AM

    Windlas Biotech Limited Share Price Information

    24 hour Low and High

    Low: 1016.25
    High: 1064.3

    All time High

    8230.60

    Price Change 1h

    +₹17.40 +1.69%

    Price Change 1d

    +₹17.40 +1.69%

    Price Change 1w

    +₹23.75 +2.32%

    Windlas Biotech Limited Market Information

    Exchange

    NSE

    Market Cap

    ₹2158.39 Cr

    About Windlas Biotech Limited Share

    Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

    Sector

    Healthcare

    Drug Manufacturers - Specialty & Generic

    Employees

    about

    1154

    CEO

    Ms. Komal Gupta

    Revenue (2023)

    NA

    NA

    Country of Origin

    India

    Key Highlights

      FAQs